OAM
GILD icon

Occidental Asset Management’s Gilead Sciences GILD Stock Holding History

Occidental Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.38M Buy
34,701
+1,325
+4% +$175K 0.44% 62
2026
Q1 		$4.65M Sell
33,376
-8,400
-20% -$1.18M 0.55% 55
2025
Q4 		$5.13M Buy
41,776
+658
+2% +$80K 0.62% 50
2025
Q3 		$4.56M Buy
41,118
+448
+1% +$50.9K 0.57% 53
2025
Q2 		$4.51M Buy
40,670
+551
+1% +$58.6K 0.62% 50
2025
Q1 		$4.5M Buy
40,119
+1,503
+4% +$155K 0.68% 41
2024
Q4 		$3.57M Buy
38,616
+3,980
+11% +$358K 0.56% 53
2024
Q3 		$2.9M Buy
34,636
+2,960
+9% +$226K 0.47% 61
2024
Q2 		$2.17M Buy
31,676
+3,101
+11% +$207K 0.38% 75
2024
Q1 		$2.09M Buy
+28,575
New +$2.2M 0.39% 73
2021
Q1 		– Sell
-18,095
Closed -$1.05M – 191
2020
Q4 		$1.05M Buy
18,095
+1,487
+9% +$89.7K 0.35% 83
2020
Q3 		$1.05M Buy
16,608
+354
+2% +$24.5K 0.44% 55
2020
Q2 		$1.25M Buy
16,254
+501
+3% +$38.4K 0.55% 37
2020
Q1 		$1.18M Buy
15,753
+2,835
+22% +$196K 0.59% 32
2019
Q4 		$839K Buy
12,918
+429
+3% +$27.9K 0.34% 83
2019
Q3 		$792K Buy
12,489
+1,860
+17% +$122K 0.33% 71
2019
Q2 		$718K Buy
10,629
+2,157
+25% +$142K 0.32% 69
2019
Q1 		$551K Buy
8,472
+1,732
+26% +$115K 0.26% 79
2018
Q4 		$422K Buy
6,740
+460
+7% +$32.2K 0.24% 84
2018
Q3 		$485K Buy
6,280
+289
+5% +$21.8K 0.24% 79
2018
Q2 		$424K Buy
5,991
+202
+3% +$14.3K 0.23% 88
2018
Q1 		$436K Sell
5,789
-40
-0.7% -$3.18K 0.24% 75
2017
Q4 		$418K Buy
5,829
+236
+4% +$17.9K 0.22% 84
2017
Q3 		$453K Buy
5,593
+146
+3% +$11.2K 0.25% 68
2017
Q2 		$386K Buy
5,447
+137
+3% +$9.12K 0.23% 76
2017
Q1 		$361K Buy
5,310
+522
+11% +$36.7K 0.24% 76
2016
Q4 		$343K Buy
+4,788
New +$356K 0.25% 77

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Occidental Asset Management's GILD Position: Q2 2026 in Review

Occidental Asset Management increased its Gilead Sciences (GILD) stake by 4% in Q2 2026, buying an estimated $175K and bringing the position to 34,701 shares worth $4.38M. The position accounts for 0.44% of the portfolio, ranked #62.

Occidental Asset Management first reported a position in GILD in Q4 2016 and has held it in 27 quarters since. The position peaked at $5.13M in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Occidental Asset Management held 34,701 shares of Gilead Sciences worth $4.38M as of Q2 2026.
  • Occidental Asset Management bought 1,325 Gilead Sciences shares in Q2 2026, an estimated $175K.
  • Gilead Sciences made up 0.44% of Occidental Asset Management's portfolio in Q2 2026, its #62 holding.
  • Occidental Asset Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 27 quarters since.
  • Occidental Asset Management's Gilead Sciences position peaked at $5.13M in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Occidental Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.